Akums Drugs & Pharma Quarterly Results for Trading Insights
AKUMS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹43 Cr
QSept 2025
Akums Drugs & Pharma Quarterly Results Key Highlights
- Revenue of ₹1,050 Cr in Sept 2025 (-2.9% vs Mar 2025, +0.0% vs Sept 2024)
- Net Profit of ₹43 Cr in Sept 2025 (-71.3% vs Mar 2025, -35.8% vs Sept 2024)
- EBITDA of ₹127 Cr in Sept 2025 (+5.8% vs Mar 2025)
- Operating Margin of 9.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹2.66 in Sept 2025 (-72.4% vs Mar 2025)
Akums Drugs & Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,050 | 1,081 | 1,051 | 1,050 | 955 | -2.9% | - |
| Net Profit (₹ Cr) | 43 | 150 | 65 | 67 | -40 | - | - |
| EBITDA (₹ Cr) | 127 | 120 | 156 | 138 | 14 | - | - |
| EPS (₹) | 2.66 | 9.64 | 4.15 | 4.37 | -2.89 | - | - |
| Operating Margin (%) | 9.0% | 9.0% | 13.0% | 12.0% | 0.0% | - | - |
Akums Drugs & Pharma Share Price Trend Around Quarterly Results
Visualize Akums Drugs & Pharma's 1-year price movement across quarterly results — ideal for logging trades in Akums Drugs & Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Akums Drugs & Pharma
Additional stock information and data for AKUMS
Revenue Trend (₹ Cr)
Sept 2024
1,050
Jun 2025
1,051
Mar 2025
1,081
Sept 2025
1,050
Net Profit Trend (₹ Cr)
Sept 2024
67
Jun 2025
65
Mar 2025
150
Sept 2025
43
Operating Margin Trend (%)
Sept 2024
12.0%
Jun 2025
13.0%
Mar 2025
9.0%
Sept 2025
9.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Akums Drugs & Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,614.47 Cr | 1704.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.1 |
|
Divis Laboratories
Sept 2025 |
₹159,931.55 Cr | 6113.5 | 2,860 | 689 | +7.1% | - | 24.1% | 235.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹133,313.66 Cr | 3997.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.9 |
|
Cipla
Sept 2025 |
₹107,433.65 Cr | 1342.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,457.10 Cr | 1275.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores